PROTAC Library

Loading...
E3 Ligase
Target
Molecular Weight
to
Your selection
  • Your selection
Structure Catalog Product Name CAS E3 Ligase Target Inquiry
Ethyl 3-(2-(tert-butylamino)-1-(3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)ethynyl)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202373 Ethyl 3-(2-(tert-butylamino)-1-(3-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)ethynyl)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-83-5

CRBN

MDM2

Inquiry

Molecular Weight: 866.29

Molecular Formula: C46H39ClF3N5O7

Boiling Point: 1082.2±65.0°C at 760 Torr

Density: 1.47±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(4-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)ethynyl)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202374 Ethyl 3-(2-(tert-butylamino)-1-(4-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)ethynyl)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-84-6

CRBN

MDM2

Inquiry

Molecular Weight: 866.29

Molecular Formula: C46H39ClF3N5O7

Boiling Point: 1082.2±65.0°C at 760 Torr

Density: 1.47±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(3-(5-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)pent-4-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202375 Ethyl 3-(2-(tert-butylamino)-1-(3-(5-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)pent-4-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-85-7

CRBN

MDM2

Inquiry

Molecular Weight: 937.37

Molecular Formula: C49H44ClF3N6O8

Boiling Point: 1169.4±65.0°C at 760 Torr

Density: 1.46±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(3-(6-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hex-5-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202376 Ethyl 3-(2-(tert-butylamino)-1-(3-(6-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hex-5-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-86-8

CRBN

MDM2

Inquiry

Molecular Weight: 951.40

Molecular Formula: C50H46ClF3N6O8

Boiling Point: 1171.1±65.0°C at 760 Torr

Density: 1.45±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(3-(7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hept-6-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202377 Ethyl 3-(2-(tert-butylamino)-1-(3-(7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hept-6-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-87-9

CRBN

MDM2

Inquiry

Molecular Weight: 965.43

Molecular Formula: C51H48ClF3N6O8

Boiling Point: 1173.0±65.0°C at 760 Torr

Density: 1.44±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(4-(5-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)pent-4-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202378 Ethyl 3-(2-(tert-butylamino)-1-(4-(5-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)pent-4-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-88-0

CRBN

MDM2

Inquiry

Molecular Weight: 937.37

Molecular Formula: C49H44ClF3N6O8

Boiling Point: 1169.4±65.0°C at 760 Torr

Density: 1.46±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(4-(6-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hex-5-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202379 Ethyl 3-(2-(tert-butylamino)-1-(4-(6-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hex-5-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-89-1

CRBN

MDM2

Inquiry

Molecular Weight: 951.40

Molecular Formula: C50H46ClF3N6O8

Boiling Point: 1171.1±65.0°C at 760 Torr

Density: 1.45±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(4-(7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hept-6-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202380 Ethyl 3-(2-(tert-butylamino)-1-(4-(7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)hept-6-ynamido)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-90-4

CRBN

MDM2

Inquiry

Molecular Weight: 965.43

Molecular Formula: C51H48ClF3N6O8

Boiling Point: 1173.0±65.0°C at 760 Torr

Density: 1.44±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(3-((3-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)prop-2-yn-1-yl)oxy)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202381 Ethyl 3-(2-(tert-butylamino)-1-(3-((3-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)prop-2-yn-1-yl)oxy)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-91-5

CRBN

MDM2

Inquiry

Molecular Weight: 896.32

Molecular Formula: C47H41ClF3N5O8

Boiling Point: 1098.1±65.0°C at 760 Torr

Density: 1.47±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(3-((4-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)but-3-yn-1-yl)oxy)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202382 Ethyl 3-(2-(tert-butylamino)-1-(3-((4-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)but-3-yn-1-yl)oxy)-N-(3,4,5-trifluorobenzyl)benzamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-92-6

CRBN

MDM2

Inquiry

Molecular Weight: 910.35

Molecular Formula: C48H43ClF3N5O8

Boiling Point: 1100.7±65.0°C at 760 Torr

Density: 1.45±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 3-(2-(tert-butylamino)-1-(7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-ethylhept-6-ynamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate BPL-202383 Ethyl 3-(2-(tert-butylamino)-1-(7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-ethylhept-6-ynamido)-2-oxoethyl)-6-chloro-1H-indole-2-carboxylate 2640723-93-7

CRBN

MDM2

Inquiry

Molecular Weight: 730.26

Molecular Formula: C39H44ClN5O7

Boiling Point: 991.7±65.0°C at 760 Torr

Density: 1.35±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

N-(2-(tert-Butylamino)-1-(4-chlorophenyl)-2-oxoethyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-ethylhept-6-ynamide BPL-202384 N-(2-(tert-Butylamino)-1-(4-chlorophenyl)-2-oxoethyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-ethylhept-6-ynamide 2640723-94-8

CRBN

MDM2

Inquiry

Molecular Weight: 619.16

Molecular Formula: C34H39ClN4O5

Boiling Point: 881.8±65.0°C at 760 Torr

Density: 1.30±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

N-(2-(tert-Butylamino)-1-(4-chlorophenyl)-2-oxoethyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamide BPL-202385 N-(2-(tert-Butylamino)-1-(4-chlorophenyl)-2-oxoethyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamide 2640723-95-9

CRBN

MDM2

Inquiry

Molecular Weight: 735.20

Molecular Formula: C39H38ClF3N4O5

Boiling Point: 938.9±65.0°C at 760 Torr

Density: 1.38±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

N-(1-(tert-Butylamino)-3-methyl-1-oxobutan-2-yl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamide BPL-202386 N-(1-(tert-Butylamino)-3-methyl-1-oxobutan-2-yl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamide 2640723-96-0

CRBN

MDM2

Inquiry

Molecular Weight: 666.74

Molecular Formula: C36H41F3N4O5

Boiling Point: 873.4±65.0°C at 760 Torr

Density: 1.30±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

N-(2-(tert-Butylamino)-1-cyclohexyl-2-oxoethyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamide BPL-202387 N-(2-(tert-Butylamino)-1-cyclohexyl-2-oxoethyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamide 2640723-97-1

CRBN

MDM2

Inquiry

Molecular Weight: 706.81

Molecular Formula: C39H45F3N4O5

Boiling Point: 909.8±65.0°C at 760 Torr

Density: 1.30±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

Ethyl 6-chloro-3-((7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamido)methyl)-1H-indole-2-carboxylate BPL-202388 Ethyl 6-chloro-3-((7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamido)methyl)-1H-indole-2-carboxylate 2640723-98-2

CRBN

MDM2

Inquiry

Molecular Weight: 747.17

Molecular Formula: C39H34ClF3N4O6

Boiling Point: 958.4±65.0°C at 760 Torr

Density: 1.47±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

N-(4-Chlorobenzyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamide BPL-202389 N-(4-Chlorobenzyl)-7-(2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)-N-(3,4,5-trifluorobenzyl)hept-6-ynamide 2640723-99-3

CRBN

MDM2

Inquiry

Molecular Weight: 636.07

Molecular Formula: C34H29ClF3N3O4

Boiling Point: 844.9±65.0°C at 760 Torr

Density: 1.42±0.1 g/cm3

Description: It is an MDM2 degrader based on ligand.

YF135 BPL-202390 YF135

VHL

KRAS G12C

Inquiry

Molecular Weight: 1179.89

Molecular Formula: C63H75ClN12O7S

Density: 1.3±0.1 g/cm3

Description: YF135 is the first reversible-covalent PROTAC capable of recruiting VHL mediated proteasomal degradation of KRASG12C. YF135 induces the rapid and sustained degradation of endogenous KRASG12C and attenuates pERK signaling in H358 and H23 cells in a reversible manner.

2-((5-(2-Chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)acetamide BPL-202391 2-((5-(2-Chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(2-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)ethyl)acetamide 2653335-21-6

CRBN

BTK
BTK C481S

Inquiry

Molecular Weight: 721.13

Molecular Formula: C36H29ClN8O7

Density: 1.534±0.06 g/cm3

Description: It is a BTK PROTAC using the selective non-covalent BTK inhibitor ARQ531 as warhead. It can improve the degradation of wild-type and C481S mutant BTKS and increase the selectivity of BTK over other kinases.

2-((5-(2-Chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butyl)acetamide BPL-202392 2-((5-(2-Chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)-N-(4-((2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)amino)butyl)acetamide 2653335-22-7

CRBN

BTK
BTK C481S

Inquiry

Molecular Weight: 749.18

Molecular Formula: C38H33ClN8O7

Density: 1.489±0.06 g/cm3

Description: It is a BTK PROTAC using the selective non-covalent BTK inhibitor ARQ531 as warhead. It can improve the degradation of wild-type and C481S mutant BTKS and increase the selectivity of BTK over other kinases.

We invite you to contact us at or through our contact form above for more information about our services and products.

USA
  • International:
  • US & Canada (Toll free):
  • Email:
  • Fax:
UK
  • Email:
Inquiry Basket